2004
DOI: 10.1016/j.febslet.2004.04.036
|View full text |Cite
|
Sign up to set email alerts
|

Ursolic acid, an antagonist for transforming growth factor (TGF)‐β1

Abstract: Transforming growth factor-beta (TGF-beta), a multifunctional cytokine which is involved in extracellular matrix modulation, has a major role in the pathogenesis and progression of fibrotic diseases. We now report the effects of ursolic acid on TGF-beta1 receptor binding and TGF-beta1-induced cellular functions in vitro. Ursolic acid inhibited [(125)I]-TGF-beta1 receptor binding to Balb/c 3T3 mouse fibroblasts with an IC(50) value of 6.9+/-0.8 microM. Ursolic acid dose-dependently recovered reduced proliferati… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
29
0

Year Published

2006
2006
2023
2023

Publication Types

Select...
7

Relationship

0
7

Authors

Journals

citations
Cited by 37 publications
(29 citation statements)
references
References 30 publications
(30 reference statements)
0
29
0
Order By: Relevance
“…Some phenolic compounds and natural triterpenoids such as oleanolic, betulinic and ursolic acids have shown notable effects in suppressing tumourigenesis, as well as in inhibiting tumours (37)(38)(39)(40). Many nutritional and non-nutritional phytochemicals with diverse biological properties have shown promise in the prevention and/or treatment of prostate cancer (41).…”
Section: Discussionmentioning
confidence: 99%
“…Some phenolic compounds and natural triterpenoids such as oleanolic, betulinic and ursolic acids have shown notable effects in suppressing tumourigenesis, as well as in inhibiting tumours (37)(38)(39)(40). Many nutritional and non-nutritional phytochemicals with diverse biological properties have shown promise in the prevention and/or treatment of prostate cancer (41).…”
Section: Discussionmentioning
confidence: 99%
“…New synthetic triterpenoids, at nanomolar concentrations, increase the expression of TGF-β-dependent genes, prolong TGF-β-induced Smad2 activation, markedly enhance the ability of Smad3 to activate Smad-binding elements in vitro, and have application in prevention or treatment of diseases like cancer and fibrosis in which there is aberrant function of TGF-β [159]. The triterpenoid ursolic acid functions as an antagonist of TGF-β and inhibits binding of TGF-β1 in mink lung epithelial cells [113]. Use of these triterpenoid agents in animal model systems will undoubtedly enhance our understanding of their potential for effectiveness.…”
Section: Tgf-β Antagonists For Inhibition Of Tumor Progressionmentioning
confidence: 99%
“…Moreover, their beneficial effects have been analysed by extensive preclinical and epidemiological studies [1][2][3][4]. Some natural triterpenoids such as oleanolic, betulinic and ursolic acids have shown notable effects in suppressing tumourigenesis as well as inhibiting tumours [1,[5][6][7][8][9]. Also, a range of newly developed synthetic triterpenoids are more potent than the naturally occurring parent structure [10,11].…”
Section: Introductionmentioning
confidence: 99%
“…Also, a range of newly developed synthetic triterpenoids are more potent than the naturally occurring parent structure [10,11]. In addition, several of these compounds induce apoptosis in a wide variety of cancer cells, including breast carcinoma, melanoma, hepatoma, prostate carcinoma and acute myelogenous leukaemia [7]. To identify potential new anticancer compounds, several pharmaceutical companies are currently evaluating extracts from plants, among these new natural triterpenoids and their derivatives [12][13][14].…”
Section: Introductionmentioning
confidence: 99%